Enpatoran Clinical Trials
3 recruitingDrug
Phase 32Phase 11
Showing 1–3 of 3 trials
Recruiting
Phase 3
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
Cutaneous Lupus ErythematosusSystematic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc.202 enrolled3 locationsNCT07355218
Recruiting
Phase 3
A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
EMD Serono Research & Development Institute, Inc.202 enrolled3 locationsNCT07332481
Recruiting
Phase 1
Effect of Renal Impairment on Enpatoran Pharmacokinetics
Renal Impairment
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany40 enrolled1 locationNCT06589713